SELINEXOR in Combination w/Bevacizumab and Atezolizumab in Newly Diagnosed Advanced Hepatocellular Carcinoma
Clinical trial NCT05093608 · TERMINATED
Trial details
- NCT number
- NCT05093608
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2022-10-12
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.